Angelos Hatzakis

Summary

Affiliation: University of Athens
Country: Greece

Publications

  1. ncbi Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV-HCV International Panel
    Vincent Soriano
    AIDS 16:813-28. 2002
  2. ncbi Evaluation of the clinical sensitivity for the quantification of human immunodeficiency virus type 1 RNA in plasma: Comparison of the new COBAS TaqMan HIV-1 with three current HIV-RNA assays--LCx HIV RNA quantitative, VERSANT HIV-1 RNA 3.0 (bDNA) and COBA
    Antigoni Katsoulidou
    Department of Hygiene and Epidemiology, National Retrovirus Reference Center, Athens University Medical School, and General Hospital of Athens G Gennimatas, Greece
    J Virol Methods 131:168-74. 2006
  3. doi The state of hepatitis B and C in the Mediterranean and Balkan countries: report from a summit conference
    A Hatzakis
    National Retrovirus Reference Center, Department of Hygiene, Epidemiology and Medical Statistics, Athens University Medical School, Athens, Greece
    J Viral Hepat 20:1-20. 2013
  4. pmc Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach
    Dimitrios Paraskevis
    Katholieke Universiteit Leuven, Rega Institute for Medical Research, Minderbroederstraat 10, B 3000 Leuven, Belgium
    Retrovirology 6:49. 2009
  5. ncbi Comparison of three current viral load assays for the quantitation of human immunodeficiency virus type 1 RNA in plasma
    Antigoni Katsoulidou
    Department of Hygiene and Epidemiology, Athens University Medical School, 75 Mikras Asias Street, GR 115 27 Athens, Goudi, Greece
    J Virol Methods 121:93-9. 2004
  6. ncbi Cellular HIV-1 DNA load predicts HIV-RNA rebound and the outcome of highly active antiretroviral therapy
    Angelos E Hatzakis
    Department of Hygiene and Epidemiology, Athens University Medical School, Athens, Greece
    AIDS 18:2261-7. 2004
  7. ncbi HBV virological assessment
    Angelos Hatzakis
    Athens University Medical School, Athens, Greece
    J Hepatol 44:S71-6. 2006
  8. doi The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference*
    A Hatzakis
    Department of Hygiene, Epidemiology and Medical Statistics, Athens University Medical School, Athens, Greece
    J Viral Hepat 18:1-16. 2011
  9. pmc Estimating the disease burden of 2009 pandemic influenza A(H1N1) from surveillance and household surveys in Greece
    Vana Sypsa
    National and Kapodistrian University of Athens, Athens, Greece
    PLoS ONE 6:e20593. 2011
  10. doi Molecular characterization of occult hepatitis B cases in Greek blood donors
    Antigoni Katsoulidou
    Department of Hygiene and Epidemiology, Athens University Medical School, Athens, Greece
    J Med Virol 81:815-25. 2009

Detail Information

Publications74

  1. ncbi Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV-HCV International Panel
    Vincent Soriano
    AIDS 16:813-28. 2002
  2. ncbi Evaluation of the clinical sensitivity for the quantification of human immunodeficiency virus type 1 RNA in plasma: Comparison of the new COBAS TaqMan HIV-1 with three current HIV-RNA assays--LCx HIV RNA quantitative, VERSANT HIV-1 RNA 3.0 (bDNA) and COBA
    Antigoni Katsoulidou
    Department of Hygiene and Epidemiology, National Retrovirus Reference Center, Athens University Medical School, and General Hospital of Athens G Gennimatas, Greece
    J Virol Methods 131:168-74. 2006
    ..96). In conclusion, the new COBAS TaqMan HIV-1 test showed excellent agreement with other widely used commercially available tests for the quantitation of HIV-1 viral load...
  3. doi The state of hepatitis B and C in the Mediterranean and Balkan countries: report from a summit conference
    A Hatzakis
    National Retrovirus Reference Center, Department of Hygiene, Epidemiology and Medical Statistics, Athens University Medical School, Athens, Greece
    J Viral Hepat 20:1-20. 2013
    ....
  4. pmc Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach
    Dimitrios Paraskevis
    Katholieke Universiteit Leuven, Rega Institute for Medical Research, Minderbroederstraat 10, B 3000 Leuven, Belgium
    Retrovirology 6:49. 2009
    ..However the spatial diffusion of the epidemic from the perspective of the virus has not previously been traced...
  5. ncbi Comparison of three current viral load assays for the quantitation of human immunodeficiency virus type 1 RNA in plasma
    Antigoni Katsoulidou
    Department of Hygiene and Epidemiology, Athens University Medical School, 75 Mikras Asias Street, GR 115 27 Athens, Goudi, Greece
    J Virol Methods 121:93-9. 2004
    ..96). The fitted regression line was described by the equation log10(LCx copies/ml) = 0.06 + 1.03 x log(10)(Monitor v1.5 copies/ml) with 95% CI for the estimated slope and intercept at 0.97, 1.09 and -0.16, 0.28, respectively...
  6. ncbi Cellular HIV-1 DNA load predicts HIV-RNA rebound and the outcome of highly active antiretroviral therapy
    Angelos E Hatzakis
    Department of Hygiene and Epidemiology, Athens University Medical School, Athens, Greece
    AIDS 18:2261-7. 2004
    ..To assess whether cellular HIV-1 DNA prior to highly active antiretroviral therapy (HAART) initiation predicts its outcome...
  7. ncbi HBV virological assessment
    Angelos Hatzakis
    Athens University Medical School, Athens, Greece
    J Hepatol 44:S71-6. 2006
    ....
  8. doi The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference*
    A Hatzakis
    Department of Hygiene, Epidemiology and Medical Statistics, Athens University Medical School, Athens, Greece
    J Viral Hepat 18:1-16. 2011
    ..Viral hepatitis knows no borders. EU Member States, guided by the EU, need to work in a concerted manner to implement lasting, effective policies and programmes and make tackling viral hepatitis a public health priority...
  9. pmc Estimating the disease burden of 2009 pandemic influenza A(H1N1) from surveillance and household surveys in Greece
    Vana Sypsa
    National and Kapodistrian University of Athens, Athens, Greece
    PLoS ONE 6:e20593. 2011
    ..The aim of this study was to assess the disease burden of the 2009 pandemic influenza A(H1N1) in Greece...
  10. doi Molecular characterization of occult hepatitis B cases in Greek blood donors
    Antigoni Katsoulidou
    Department of Hygiene and Epidemiology, Athens University Medical School, Athens, Greece
    J Med Virol 81:815-25. 2009
    ..HBsAg diagnostic failure and low viral replication in occult HBV infection carriers could possibly be attributed to multiple changes in envelope and polymerase regions, respectively...
  11. doi The effect of antiretroviral treatment of different durations in primary HIV infection
    Nikos Pantazis
    Department of Hygiene, Epidemiology and Medical Statistics, Athens University Medical School, Athens, Greece
    AIDS 22:2441-50. 2008
    ....
  12. ncbi Human herpesvirus 8 (HHV-8) infection in healthy urban employees from Greece: seroprevalence and associated factors
    Assimina Zavitsanou
    Department of Hygiene and Epidemiology, Athens University Medical School, Athens, Greece
    J Med Virol 79:591-6. 2007
    ..The association between HHV-8 seropositivity and endoscopic examination requires further investigation...
  13. pmc Quantitation of human immunodeficiency virus type 1 DNA forms with the second template switch in peripheral blood cells predicts disease progression independently of plasma RNA load
    Leondios G Kostrikis
    Department of Hygiene and Epidemiology, Athens University Medical School, 75 Mikras Asias, 11527 Athens, Greece
    J Virol 76:10099-108. 2002
    ..This parameter may have important implications for understanding the virological response to combination antiretroviral therapy...
  14. doi Dating the origin and dispersal of hepatitis B virus infection in humans and primates
    Dimitrios Paraskevis
    Department of Hygiene, Epidemiology and Medical Statistics, Medical School, University of Athens, Athens, Greece
    Hepatology 57:908-16. 2013
    ..hepatology 2013)...
  15. ncbi Changes in T cell receptor excision DNA circle (TREC) levels in HIV type 1-infected subjects pre- and post-highly active antiretroviral therapy
    Giota Touloumi
    Department of Hygiene and Epidemiology, Athens University Medical School, Athens, Greece
    AIDS Res Hum Retroviruses 20:47-54. 2004
    ..TREC values, which likely represent a simple indicator of naive T-lymphocyte reserve, may be a clinically useful marker for long-term prognosis of HIV-1 infection and for immune reconstitution after successful HAART...
  16. ncbi Human herpesvirus 8 infection in hemodialysis patients
    Assimina Zavitsanou
    Department of Hygiene and Epidemiology, Athens University Medical School, Athens, Greece
    Am J Kidney Dis 47:167-70. 2006
    ..The aim of the present study was to evaluate human herpesvirus 8 (HHV-8) seroprevalence in Greek hemodialysis patients. Patterns of change in HHV-8 serostatus (seroconversions and seroreversions) over time were also evaluated...
  17. pmc Development of a new ultra sensitive real-time PCR assay (ultra sensitive RTQ-PCR) for the quantification of HBV-DNA
    Dimitrios Paraskevis
    Department of Hygiene Epidemiology and Medical Statistics, Medical School, University of Athens, Athens, Greece
    Virol J 7:57. 2010
    ..Improved sensitivity of HBV-DNA tests is of critical importance for the management of HBV infection. Our aim was to develop and assess a new ultra sensitive in-house real-time PCR assay for HBV-DNA quantification (ultra sensitive RTQ-PCR)...
  18. ncbi Phylogenetic reconstruction of a known HIV-1 CRF04_cpx transmission network using maximum likelihood and Bayesian methods
    Dimitrios Paraskevis
    National Retrovirus Reference Center, Department of Hygiene and Epidemiology, Athens University Medical School, Athens, Greece
    J Mol Evol 59:709-17. 2004
    ..For patients with known infection dates, the estimated dates of the coalescent events obtained using molecular clock calculations based on a newly developed Bayesian method in gag + env were in agreement with the actual infection dates...
  19. ncbi Increasing prevalence of HIV-1 subtype A in Greece: estimating epidemic history and origin
    Dimitrios Paraskevis
    Department of Hygiene and Epidemiology, National Retrovirus Reference Center, Athens, Greece
    J Infect Dis 196:1167-76. 2007
    ..In North America and Europe, human immunodeficiency virus (HIV)-1 infection has typically been dominated by subtype B transmission. More recently, however, non-B subtypes have been increasingly reported in Europe...
  20. doi Effect of HIV type 1 subtype on virological and immunological response to combination antiretroviral therapy: evidence for a more rapid viral suppression for subtype A than subtype B-infected Greek individuals
    Dimirios Paraskevis
    Department of Hygiene, Epidemiology and Medical Statistics, Athens Medical School, University of Athens, Athens, Greece
    AIDS Res Hum Retroviruses 29:461-9. 2013
    ....
  21. doi Time of acquisition of HCV infection in renal transplant recipients: a major prognostic factor for disease progression
    Ioanna Delladetsima
    First Department of Pathology, National and Kapodistrian University of Athens, Athens, Greece
    Clin Transplant 27:72-9. 2013
    ..This study aims to identify crucial factors affecting the evolution of liver disease in HCV-infected renal transplant recipients...
  22. doi Risk associations of melanoma in a Southern European population: results of a case/control study
    Vasiliki A Nikolaou
    Department of Dermatology, University of Athens, Andreas Sygros Hospital, 5 Dragoumi Street, Athens, 10671, Greece
    Cancer Causes Control 19:671-9. 2008
    ..We investigated the association of melanoma with phenotypic and solar indices in this darker skin population residing in an environment of high ambient ultraviolet radiation...
  23. doi Emergence of an NNRTI resistance mutation Y181C in an HIV-infected NNRTI-naive patient
    Emmanouil Magiorkinis
    Department of Hygiene and Epidemiology, University of Athens Medical School, GR 11527 Athens, Greece
    AIDS Res Hum Retroviruses 24:413-5. 2008
    ..The genetic barrier against resistance of this combination may be lower than previously thought...
  24. ncbi Differences in HIV RNA levels before the initiation of antiretroviral therapy among 1864 individuals with known HIV-1 seroconversion dates
    Giota Touloumi
    Department of Hygiene and Epidemiology, Athens Univerity Medical School, Greece
    AIDS 18:1697-705. 2004
    ..To assess the effects of sex, risk group, age at and year of seroconversion (SC), and presentation during acute infection on HIV RNA trends before antiretroviral therapy (ART) initiation...
  25. doi Assessment of phylogenetic sensitivity for reconstructing HIV-1 epidemiological relationships
    Apostolos Beloukas
    National Retrovirus Reference Center, Department of Hygiene, Epidemiology and Medical Statistics, Athens, Greece
    Virus Res 166:54-60. 2012
    ..We report that under the conditions of our study, hML using PhyML, NJ and Bayesian methods were the most sensitive for the reconstruction of epidemiological links mostly from sexually infected individuals...
  26. pmc Comparative evaluation of the performance of the Abbott RealTime HIV-1 assay for measurement of HIV-1 plasma viral load on genetically diverse samples from Greece
    Antigoni Katsoulidou
    National Retrovirus Reference Center, Department of Hygiene and Epidemiology and Medical Statistics, Athens University Medical School, Goudi, Greece
    Virol J 8:10. 2011
    ..HIV-1 is characterized by increased genetic heterogeneity which tends to hinder the reliability of detection and accuracy of HIV-1 RNA quantitation assays...
  27. doi Modelling of viral dynamics in hepatitis B and hepatitis C clinical trials
    Vana Sypsa
    Department of Hygiene and Epidemiology, Athens University Medical School, M Asias 75, Athens 11527, Greece
    Stat Med 27:6505-21. 2008
    ..Real data examples from a clinical trial on hepatitis B are provided as illustrations...
  28. ncbi In vivo characteristics of human immunodeficiency virus type 1 intersubtype recombination: determination of hot spots and correlation with sequence similarity
    Gkikas Magiorkinis
    National Retrovirus Reference Center, Department of Hygiene and Epidemiology, Athens University Medical School, Mikras Asias 75, 11527 Athens, Greece
    J Gen Virol 84:2715-22. 2003
    ..This finding suggests that recombination in vivo may occur preferentially during reverse transcription through the strand displacement-assimilation model rather than the copy-choice model...
  29. doi Prevalence of different HPV types and estimation of prognostic risk factors based on the linear array HPV genotyping test
    Eleni Papachristou
    Department of Hygiene Epidemiology and Medical Statistics, School of Medicine, University of Athens, Athens, Greece
    J Med Virol 81:2059-65. 2009
    ..5, 6.3)] and no history of child birth [no vs. yes: OR = 2.6, 95% CI: (1.0, 6.7)]. Younger age was an additional risk factor for HPV infection with carcinogenic genotypes [OR for 1 year increase = 0.93, 95% CI: (0.89, 0.98)]...
  30. doi Impact of hepatitis B virus infection on the progression of AIDS and mortality in HIV-infected individuals: a cohort study and meta-analysis
    Georgios K Nikolopoulos
    Department of Hygiene, Epidemiology, and Medical Statistics, School of Medicine, University of Athens, Athens GR 11527, Greece
    Clin Infect Dis 48:1763-71. 2009
    ..Moreover, our results were added to those of previous studies in a literature-based meta-analysis...
  31. pmc The global spread of hepatitis C virus 1a and 1b: a phylodynamic and phylogeographic analysis
    Gkikas Magiorkinis
    Department of Hygiene, Epidemiology and Medical Statistics, Medical School, University of Athens, Athens, Greece
    PLoS Med 6:e1000198. 2009
    ..However, epidemiological data suggest that the expansion of HCV may have occurred after the Second World War. The aim of our study was to elucidate the timescale and route of the global spread of HCV...
  32. doi HBV viremia in newborns of HBsAg(+) predominantly Caucasian HBeAg(-) mothers
    Vassiliki Papaevangelou
    Second Department of Pediatrics, P and A Kyriakou Children s Hospital, Medical School, Athens University, Goudi 11527, Athens, Greece
    J Clin Virol 50:249-52. 2011
    ..Although, immunoprophylaxis given at birth largely prevents mother-to-infant transmission, perinatal HBV viremia has been reported in HBsAg(-) newborns born mainly to HBeAg(+) women in endemic areas...
  33. pmc Integrating phylodynamics and epidemiology to estimate transmission diversity in viral epidemics
    Gkikas Magiorkinis
    Department of Hygiene, Epidemiology and Medical Statistics, Medical School, University of Athens, Athens, Greece
    PLoS Comput Biol 9:e1002876. 2013
    ..We anticipate that this integrated approach will form the basis of powerful tools for describing the transmission dynamics of chronic viral diseases, and for evaluating control strategies directed against them...
  34. doi Appearance of a single amino acid insertion at position 33 in HIV type 1 protease under a lopinavir-containing regimen, associated with reduced protease inhibitor susceptibility
    Emmanouil Magiorkinis
    Department of Hygiene, Epidemiology and Medical Statistics, Medical School, University of Athens, Greece
    AIDS Res Hum Retroviruses 27:1223-9. 2011
    ..The L33ins might have a potential role in PI resistance pathways but further investigation in a larger number of clinical samples is required in order to elucidate this resistance mechanism...
  35. doi Rates and determinants of virologic and immunological response to HAART resumption after treatment interruption in HIV-1 clinical practice
    Giota Touloumi
    Department of Hygiene, Epidemiology, and Medical Statistics, Athens University Medical School, Athens, Greece
    J Acquir Immune Defic Syndr 49:492-8. 2008
    ..To describe CD4 and HIV RNA changes during treatment resumption (TR) after treatment interruption (TI) compared with response to first highly active antiretroviral therapy (HAART) and to investigate predictors...
  36. ncbi The role of HIV-1 DNA as an additional marker of HIV-1 infection
    Apostolos Beloukas
    Department of Hygiene, Epidemiology and Medical Statistics, Medical School, Athens University, Greece
    Curr HIV Res 7:255-65. 2009
    ..The lack of a standardized real-time PCR assay is major impediment to more wide-spread HIV-1 DNA monitoring...
  37. doi Apoptosis and hepatitis C virus infection in renal transplant recipients
    Ioanna Delladetsima
    Department of Pathology, Laiko General Hospital, Athens, Greece
    Am J Clin Pathol 129:744-8. 2008
    ..In HCV-infected renal transplant recipients, apoptotic cell death seems to be associated with high viral load, thus providing indications of viral interference in the pathogenetic process...
  38. doi Significance of liver histology in HBsAg-positive, IgM anti-HBc-negative acute hepatitis B virus-related hepatitis
    Ioanna Delladetsima
    1st Department of Pathology 2nd, Medical School, National and Kapodistrian University of Athens, Athens, Greece
    Histopathology 61:881-8. 2012
    ..The aim of this study was to evaluate the prognostic significance of histological features and hepatic expression of HBV antigens in such patients...
  39. ncbi Genetic evolution of human immunodeficiency virus type 1 in two spouses responding successfully to highly active antiretroviral therapy
    Cleo G Anastassopoulou
    National Retrovirus Reference Center, Department of Hygiene and Epidemiology, Athens University Medical School, Greece
    AIDS Res Hum Retroviruses 19:65-71. 2003
    ..These findings reinforce the evidence of a crucial role for host-selective constraints on HIV-1 env evolution in vivo...
  40. ncbi Incidence and patterns of hepatitis C virus seroconversion in a cohort of hemodialysis patients
    Vana Sypsa
    Athens University Medical School, Athens, Greece
    Am J Kidney Dis 45:334-43. 2005
    ....
  41. doi Impact of HIV type 1 DNA levels on spontaneous disease progression: a meta-analysis
    Chrissa G Tsiara
    Department of Hygiene, Epidemiology and Medical Statistics, Medical School, University of Athens, Greece
    AIDS Res Hum Retroviruses 28:366-73. 2012
    ..51, 95% CI: 1.11-2.05). HIV-1 DNA is a strong predictor of HIV-1 disease progression. Moreover, there is some evidence that HIV-1 DNA might have better predictive value than plasma HIV-1 RNA...
  42. ncbi Association of clinical progression in classic Kaposi's sarcoma with reduction of peripheral B lymphocytes and partial increase in serum immune activation markers
    Alexander J Stratigos
    Department of Dermatology, University of Athens, Andreas Sygros Hospital, Athens, Greece
    Arch Dermatol 141:1421-6. 2005
    ..To evaluate various immunologic markers in the peripheral blood of patients with early and advanced classic Kaposi's sarcoma (CKS)...
  43. pmc Transmission dynamics of carbapenemase-producing Klebsiella pneumoniae and anticipated impact of infection control strategies in a surgical unit
    Vana Sypsa
    Department of Hygiene, Epidemiology and Medical Statistics, Athens University Medical School, Athens, Greece
    PLoS ONE 7:e41068. 2012
    ..Transmission from patient to patient via the hands of healthcare workers is the main route of spread in the acute-care setting...
  44. pmc Economic recession and emergence of an HIV-1 outbreak among drug injectors in athens metropolitan area: a longitudinal study
    Dimitrios Paraskevis
    National Retrovirus Reference Center, Department of Hygiene, Epidemiology and Medical Statistics, Medical School, University of Athens, Athens, Greece
    PLoS ONE 8:e78941. 2013
    ..During 2011, a dramatic increase (1600%) of reported HIV-1 infections among injecting drug users (IDUs) was noted in Athens, Greece. We herein assess the potential causal pathways associated with this outbreak...
  45. pmc Early hCG addition to rFSH for ovarian stimulation in IVF provides better results and the cDNA copies of the hCG receptor may be an indicator of successful stimulation
    Peter Drakakis
    IVF Unit, Alexandra Hospital, 1st Department of Obstetrics and Gynecology, Athens University Medical School, Athens, Greece
    Reprod Biol Endocrinol 7:110. 2009
    ..The determination of cDNA copies could be, in the future, a marker during ovulation induction protocols and of course a predictor for the outcome of ART in the special subgroup of patients with previous failures...
  46. pmc Ultrasensitive amplification refractory mutation system real-time PCR (ARMS RT-PCR) assay for detection of minority hepatitis B virus-resistant strains in the era of personalized medicine
    Fotinie Ntziora
    Department of Hygiene, Epidemiology, and Medical Statistics, University of Athens Medical School, Athens, Greece
    J Clin Microbiol 51:2893-900. 2013
    ..These observations need further evaluation with prospective studies before they can be implemented in daily practice. ..
  47. ncbi Melanocortin receptor-1 gene polymorphisms and the risk of cutaneous melanoma in a low-risk southern European population
    Alexander J Stratigos
    Department of Dermatology, University of Athens Medical School, Andreas Sygros Hospital, Athens, Greece
    J Invest Dermatol 126:1842-9. 2006
    ..In conclusion, MC1R polymorphisms are a predisposing factor of melanoma in a southern European population with a relatively low incidence of the disease...
  48. pmc Role of combination antiviral therapy in pandemic influenza and stockpiling implications
    Sotirios Tsiodras
    Fourth Academic Department of Internal Medicine, University of Athens Medical School, Athens 12462, Greece
    BMJ 334:293-4. 2007
  49. ncbi A viral kinetic study using pegylated interferon alfa-2b and/or lamivudine in patients with chronic hepatitis B/HBeAg negative
    Vassiliki Anastasia Sypsa
    Athens University Medical School, Greece
    Hepatology 42:77-85. 2005
    ..Supplementary material for this article can be found on the HEPATOLOGY website (http://www.interscience.wiley.com/jpages/0270-9139/suppmat/index.html)...
  50. doi Public health issues of hepatitis C virus infection
    George Papatheodoridis
    2nd Department of Internal Medicine, Athens University Medical School, Hippokration General Hospital, Athens, Greece
    Best Pract Res Clin Gastroenterol 26:371-80. 2012
    ..Given the high efficacy of treatment, public health authorities should recognise the importance of HCV and make resources available for the implementation of effective primary prevention, screening and management policies...
  51. doi A cost-utility analysis of hypertension treatment in Greece: assessing the impact of age, sex and smoking status, on outcomes
    Kostas Athanasakis
    Department of Hygiene, Epidemiology and Medical Statistics, Athens University Medical School, Athens, Greece
    J Hypertens 30:227-34. 2012
    ..To assess the cost-utility of hypertension treatment versus a hypothetical 'no-treatment' strategy in Greece...
  52. ncbi The course of hepatitis C virus infection in pretransplantation anti-hepatitis C virus-negative renal transplant recipients: a retrospective follow-up study
    Ioanna Delladetsima
    Department of Pathology, Transplant Center, Laiko General Hospital, Athens University Medical School, Athens, Greece
    Am J Kidney Dis 47:309-16. 2006
    ..The aim of this study is to evaluate the natural course of hepatitis C virus (HCV) infection in renal transplant recipients infected shortly before or after renal transplantation...
  53. doi Genetic variants in immunoregulatory genes and risk for childhood lymphomas
    Elisabeth Andrie
    Department of Hygiene, Epidemiology and Medical Statistics, Athens University Medical School, 75 Mikras Asias Str, Goudi, Athens, Greece
    Eur J Haematol 83:334-42. 2009
    ....
  54. doi Clinicopathological features and natural history of acute sporadic non-(A-E) hepatitis
    Nicolaos C Tassopoulos
    National Retrovirus Reference Center, Department of Hygiene and Epidemiology, Athens University Medical School, Athens, Greece
    J Gastroenterol Hepatol 23:1208-15. 2008
    ....
  55. ncbi Recent thymic emigrants and prognosis in T- and B-cell childhood hematopoietic malignancies
    Eleni Petridou
    Department of Hygiene and Epidemiology, Athens University Medical School, Greece
    Int J Cancer 101:74-7. 2002
    ..These preliminary findings can be used as hypothesis-generating indications that should be confirmed in larger data sets...
  56. ncbi Reanalysis of the HIV-1 circulating recombinant form A/E (CRF01_AE): evidence of A/E/G recombination
    Gkikas Magiorkinis
    National Retrovirus Reference Center, Department of Hygiene and Epidemiology, Athens University Medical School, Athens, Greece
    J Acquir Immune Defic Syndr 30:124-9. 2002
    ..These findings provide evidence that CRF01_AE originated from recombination between at least three different subtypes...
  57. doi Gender differences in HIV progression to AIDS and death in industrialized countries: slower disease progression following HIV seroconversion in women
    Inmaculada Jarrin
    National Center of Epidemiology, Instituto de Salud Carlos III, Madrid, Spain
    Am J Epidemiol 168:532-40. 2008
    ..74, 95% CI: 0.56, 0.98). Sex differences in HIV disease progression have become larger and statistically significant in the era of highly active antiretroviral therapy, supporting a stronger impact of health interventions among women...
  58. ncbi End-stage liver disease in persons with hemophilia and transfusion-associated infections
    James J Goedert
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA
    Blood 100:1584-9. 2002
    ..04-fold (95% CI, 1.03-1.06) per year of age. Thus, HIV is associated with a markedly increased risk of HCV-related ESLD for persons with hemophilia, particularly with HBV infection, low CD4(+) lymphocytes, or older age...
  59. pmc Persistent HIV-1 infection of natural killer cells in patients receiving highly active antiretroviral therapy
    Antonio Valentin
    Human Retrovirus Section, Basic Research Laboratory, National Cancer Institute, Frederick, MD 21702, USA
    Proc Natl Acad Sci U S A 99:7015-20. 2002
    ..The properties of the virus reservoir in these cells should be considered in attempts to further optimize antiretroviral therapies...
  60. ncbi Changes over calendar time in the risk of specific first AIDS-defining events following HIV seroconversion, adjusting for competing risks
    Abdel Babiker
    Int J Epidemiol 31:951-8. 2002
    ..We wished to evaluate changes over time in the risk of specific AIDS-defining diseases, as first events, using data from individuals with known dates of HIV seroconversion...
  61. ncbi Management of antiviral resistance in patients with chronic hepatitis B
    Stephen Locarnini
    Victorian Infectious Diseases Reference Laboratory, North Melbourne, Vic, Australia
    Antivir Ther 9:679-93. 2004
    ..Potential strategies to prevent the emergence of resistance and how to manage drug-resistant HBV once it emerges are discussed...
  62. ncbi Risk of cancers during interrupted antiretroviral therapy in the SMART study
    Michael J Silverberg
    Division of Research, Kaiser Permanente Northern California, Oakland, California 94110, USA
    AIDS 21:1957-63. 2007
    ..To compare rates of AIDS-defining and non-AIDS-defining malignancies between patients on a CD4 T-cell-guided antiretroviral therapy (ART) strategy and continuous ART...
  63. ncbi Interruption of antiretroviral therapy and risk of cardiovascular disease in persons with HIV-1 infection: exploratory analyses from the SMART trial
    Andrew N Phillips
    Department of Primary Care and Population Sciences, Royal Free University College Medical School, London, UK
    Antivir Ther 13:177-87. 2008
    ..Exploratory analyses were performed to better understand the reasons for this observation...
  64. ncbi Dynamics of drug-resistant HIV-1 in plasma and peripheral blood cells in patients during and after enfuvirtide therapy
    Eva Poveda
    Department of Infectious Diseases, Hospital Carlos III, Madrid, Spain
    AIDS Res Hum Retroviruses 23:1078-82. 2007
    ....
  65. ncbi Impact of parietal cell autoantibodies and non-organ-specific autoantibodies on the treatment outcome of patients with hepatitis C virus infection: a pilot study
    Nikolaos K Gatselis
    Department of Internal Medicine, Research Laboratory of Internal Medicine, Medical School, University of Thessaly, Larissa, Greece
    World J Gastroenterol 11:482-7. 2005
    ....
  66. ncbi Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV International Panel
    Vincent Soriano
    Department of Infectious Diseases, Hospital Carlos III, Calle Sinesio Delgado 10, 28029 Madrid, Spain
    AIDS 21:1073-89. 2007
  67. pmc Virologic monitoring of hepatitis B virus therapy in clinical trials and practice: recommendations for a standardized approach
    Jean Michel Pawlotsky
    French National Reference Center for Viral Hepatitis B, C and delta, Department of Virology, Henri Mondor Hospital, University of Paris XII, Creteil, France
    Gastroenterology 134:405-15. 2008
    ..This article discusses HBV virologic markers and tests, and their optimal use both for planning and reporting clinical trials and in clinical practice...
  68. doi Comments on "the distribution of HIV-1 recombination breakpoints" by Jun Fan, Matteo Negroni, David L. Robertson
    Gkikas Magiorkinis
    Infect Genet Evol 8:527-8. 2008
  69. ncbi The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different HIV-1 subtypes
    David A van de Vijver
    Eijkman Winkler Institute, Department of Virology, University Medical Center Utrecht, G04 614, 3584 CX Utrecht, The Netherlands
    J Acquir Immune Defic Syndr 41:352-60. 2006
    ..This study compared the genetic barrier between subtypes using some 2000 HIV-1 sequences (>600 of non-B subtype) isolated from anti-retroviral-naive patients in Europe...
  70. ncbi HBsAg-negative HBV mutant transfusion-related acute hepatitis B
    Maria Schina
    Am J Gastroenterol 102:216-7. 2007
  71. ncbi Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management
    Annemarie M J Wensing
    Eijkman Winkler Institute, Department of Virology, University Medical Center Utrecht, The Netherlands
    J Infect Dis 192:958-66. 2005
    ..Widespread transmission of drug-resistant variants has the disturbing potential of limiting future therapy options and affecting the efficacy of postexposure prophylaxis...
  72. ncbi Care of patients with hepatitis C and HIV co-infection
    Vincent Soriano
    AIDS 18:1-12. 2004
  73. ncbi Investigation of SEN virus infection in patients with cryptogenic acute liver failure, hepatitis-associated aplastic anemia, or acute and chronic non-A-E hepatitis
    Takeji Umemura
    Department of Transfusion Medicine, Warren Grant Magnuson Clinical Center, National Heart, Lung, Blood Institute, National Institutes of Health, Bethesda, Maryland 20892 1184, USA
    J Infect Dis 188:1545-52. 2003
    ..The severity of acute or chronic hepatitis A, B, or C was not influenced by coexisting SENV infection. No etiological role for SENV in the cause of cryptogenic hepatitis could be demonstrated...
  74. doi Changes in the risk of death after HIV seroconversion compared with mortality in the general population
    Krishnan Bhaskaran
    MRC Clinical Trials Unit, 222 Euston Rd, London NW1 2DA, United Kingdom
    JAMA 300:51-9. 2008
    ..Mortality among human immunodeficiency virus (HIV)-infected individuals has decreased dramatically in countries with good access to treatment and may now be close to mortality in the general uninfected population...